​

Xeris Biopharma (XERS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Xeris Biopharma Revenue Highlights

Latest Revenue (Y)

$291.85M

Latest Revenue (Q)

$71.54M

Main Segment (Y)

Product

Xeris Biopharma Revenue by Period

Xeris Biopharma Revenue by Year

DateRevenueChange
2025-12-31$291.85M43.72%
2024-12-31$203.07M23.89%
2023-12-31$163.91M48.68%
2022-12-31$110.25M122.32%
2021-12-31$49.59M142.67%
2020-12-31$20.43M650.73%
2019-12-31$2.72M10.43%
2018-12-31$2.46M58.42%
2017-12-31$1.56M44.74%
2016-12-31$1.07M-

Xeris Biopharma generated $291.85M in revenue during NA 2025, up 43.72% compared to the previous quarter, and up 1428.16% compared to the same period a year ago.

Xeris Biopharma Revenue by Quarter

DateRevenueChange
2025-06-30$71.54M19.00%
2025-03-31$60.12M0.03%
2024-12-31$60.10M10.74%
2024-09-30$54.27M12.91%
2024-06-30$48.06M18.28%
2024-03-31$40.64M-8.45%
2023-12-31$44.39M-8.13%
2023-09-30$48.32M27.13%
2023-06-30$38.01M14.50%
2023-03-31$33.20M0.16%
2022-12-31$33.14M11.50%
2022-09-30$29.73M17.46%
2022-06-30$25.31M14.65%
2022-03-31$22.07M3.01%
2021-12-31$21.43M94.19%
2021-09-30$11.04M23.91%
2021-06-30$8.91M10.62%
2021-03-31$8.05M13.57%
2020-12-31$7.09M-24.97%
2020-09-30$9.45M366.11%
2020-06-30$2.03M13.37%
2020-03-31$1.79M-4.08%
2019-12-31$1.86M477.09%
2019-09-30$323.00K0.94%
2019-06-30$320.00K29.03%
2019-03-31$248.00K-69.04%
2018-12-31$801.00K37.63%
2018-09-30$582.00K-28.94%
2018-06-30$819.00K211.41%
2018-03-31$263.00K-43.68%
2017-12-31$467.00K174.71%
2017-09-30$170.00K-69.91%
2017-06-30$565.00K59.60%
2017-03-31$354.00K-

Xeris Biopharma generated $71.54M in revenue during Q2 2025, up 19.00% compared to the previous quarter, and up 176.04% compared to the same period a year ago.

Xeris Biopharma Revenue Breakdown

Xeris Biopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22
Product$283.00M$196.64M$153.36M$109.26M
Keveyis$47.65M$49.53M$56.77M$49.31M
Product, Other$1.96M---

Xeris Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (85.08%), Keveyis (14.33%), and Product, Other (0.59%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22
Product, Other$651.00K$1.31M------------
Product$83.43M$74.06M$67.71M$57.80M$103.51M$52.86M$40.26M$111.67M$41.70M$36.89M$32.27M$32.54M$29.55M$25.26M
Keveyis$12.80M$11.94M$11.48M$11.43M$24.25M$12.19M$13.09M$40.91M$15.87M$14.09M$12.76M$13.80M$13.37M$12.81M

Xeris Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (86.12%), Keveyis (13.21%), and Product, Other (0.67%).

Xeris Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BCRXBioCryst Pharmaceuticals$874.84M$159.40M
HRMYHarmony Biosciences$868.45M$239.46M
IMCRImmunocore$400.02M$103.69M
XERSXeris Biopharma$291.85M$71.54M
MAZEMaze Therapeutics$167.50M-
ABCLAbCellera Biologics$75.13M$8.96M
JANXJanux Therapeutics$10.00M$10.00M
CLDXCelldex Therapeutics$1.54M-
SIONSionna Therapeutics--
VERAVera Therapeutics--
BHVNBiohaven--

XERS Revenue FAQ

What is Xeris Biopharma’s yearly revenue?

Xeris Biopharma's yearly revenue for 2025 was $291.84M, representing an increase of 43.72% compared to 2024. The company's yearly revenue for 2024 was $203.07M, representing an increase of 23.89% compared to 2023. XERS's yearly revenue for 2023 was $163.91M, representing an increase of 48.68% compared to 2022.

What is Xeris Biopharma’s quarterly revenue?

Xeris Biopharma's quarterly revenue for Q2 2025 was $71.54M, a 19.00% increase from the previous quarter (Q1 2025), and a 48.84% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $60.12M, a 0.03% increase from the previous quarter (Q4 2024), and a 47.94% increase year-over-year (Q1 2024). XERS's quarterly revenue for Q4 2024 was $60.1M, a 10.74% increase from the previous quarter (Q3 2024), and a 35.39% increase year-over-year (Q4 2023).

What is Xeris Biopharma’s revenue growth rate?

Xeris Biopharma's revenue growth rate for the last 3 years (2023-2025) was 78.05%, and for the last 5 years (2021-2025) was 488.52%.

What are Xeris Biopharma’s revenue streams?

Xeris Biopharma's revenue streams in c 25 are Product, Keveyis, and Product, Other. Product generated $283M in revenue, accounting 85.08% of the company's total revenue, up 43.92% year-over-year. Keveyis generated $47.65M in revenue, accounting 14.33% of the company's total revenue, down -3.80% year-over-year. Product, Other generated $1.96M in revenue, accounting 0.59% of the company's total revenue

What is Xeris Biopharma’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Xeris Biopharma was Product. This segment made a revenue of $283M, representing 85.08% of the company's total revenue.